Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Free Cash Flow: 2017-2024

Historic Free Cash Flow for Bicycle Therapeutics (BCYC) over the last 8 years, with Dec 2024 value amounting to -$166.0 million.

  • Bicycle Therapeutics' Free Cash Flow fell 78.43% to -$71.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$241.9 million, marking a year-over-year decrease of 18.83%. This contributed to the annual value of -$166.0 million for FY2024, which is 161.12% down from last year.
  • Latest data reveals that Bicycle Therapeutics reported Free Cash Flow of -$166.0 million as of FY2024, which was down 161.12% from -$63.6 million recorded in FY2023.
  • In the past 5 years, Bicycle Therapeutics' Free Cash Flow ranged from a high of -$16.8 million in FY2021 and a low of -$166.0 million during FY2024.
  • In the last 3 years, Bicycle Therapeutics' Free Cash Flow had a median value of -$105.1 million in 2022 and averaged -$111.5 million.
  • Per our database at Business Quant, Bicycle Therapeutics' Free Cash Flow tumbled by 524.69% in 2022 and then skyrocketed by 39.53% in 2023.
  • Yearly analysis of 5 years shows Bicycle Therapeutics' Free Cash Flow stood at -$19.0 million in 2020, then increased by 11.40% to -$16.8 million in 2021, then slumped by 524.69% to -$105.1 million in 2022, then soared by 39.53% to -$63.6 million in 2023, then tumbled by 161.12% to -$166.0 million in 2024.